Category Archives: Patient Communication

Rare Disease Day: Spotlight on Solidarity

By Jennifer Ringler | Published: February 28, 2012

Patients, policymakers and pharmaceutical companies are uniting around rare diseases on the rarest of calendar days, presaging a leap forward in health outcomes and business opportunities. Aligning humanistic objectives with business incentives is often the sine qua non of effective community activism. This year’s Rare Disease Day – hosted in the US by the National [...]

Also posted in Events, FDA, Global, Strategy, healthcare, leadership, patient education, social media | Tagged FDA, NIH, NORD, orphan diseases, patient groups, patient information, Rare Disease Day, rare diseases | Leave a comment

The Rising Clout of the Patient

By Guest Blogger | Published: January 9, 2012

by Sarah Krüg In 2011, the patient’s clout as a stakeholder was firmly established, as reflected in several industry conferences. What’s next for the patient in 2012?

Also posted in Events, Meetings, Strategy, Technology, leadership, patient education, social media | Tagged e-Patient Connections Conference, patient communication, patient groups | 1 Comment

The Rise of the Patient: Medicine 2.0

By Guest Blogger | Published: October 12, 2011

by Sarah Krüg Amidst yellow sandstone arches and California Mission Revival architecture, The Medicine 2.0 +Stanford Summit (otherwise known as the Fourth World Congress on Social Media and Web 2.0 in Health Medicine) set out on a three day journey to challenge its diverse audience to break down silos and expand beyond traditional boundaries. From a [...]

Also posted in Meetings, Strategy, Technology, healthcare, leadership, patient compliance, patient education, social media | Tagged patient groups, patient information | Leave a comment

Pfizer CEO: DTC a 'Fundamental Right'

By Ben Comer | Published: October 5, 2011

Direct-to-consumer (DTC) advertising is a “fundamental right in the U.S.,” and denying the right of industry to speak directly to patients through drug advertising “leads to ignorance and the inability to judge,” said Ian Read, Pfizer’s president and CEO, at the Cleveland Clinic on Tuesday. Asked whether DTC ads on television should be retired, Read answered [...]

Also posted in Advertising, IP, Marketing, Regulatory, Strategy, leadership, patient education | Tagged DTC, Pfizer CEO | 7 Comments

Value Isn't Just Dollars and Cents, says Pfizer Exec

By Ben Comer | Published: September 23, 2011

Now that 90% of the top 43 countries for drug sales have instituted “significant” cost containment measures, it’s more important than ever to give payers the rest of the story, according to a Pfizer executive.

Also posted in Europe, Global, Market Access, Marketing, Strategy, healthcare, pricing | Tagged reimbursement | Leave a comment